Bayforest Capital’s SpringWorks Therapeutics SWTX Stock Holding History

Bayforest Capital’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-57	Closed	-$2.68K	–	914
2025 Q2	$2.68K	Buy	+57	New	+$2.54K	﹤0.01%	688
2025 Q1	–	Sell	-315	Closed	-$11.4K	–	891
2024 Q4	$11.4K	Buy	+315	New	+$11K	0.01%	621

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Bayforest Capital's SWTX Position: Q3 2025 in Review

Bayforest Capital sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 57 shares — an estimated $2.68K sold.

Bayforest Capital first reported a position in SWTX in Q4 2024 and held it in 2 quarters. The position peaked at $11.4K in Q4 2024. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

Bayforest Capital reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
Bayforest Capital sold 57 SpringWorks Therapeutics shares in Q3 2025, an estimated $2.68K.
Bayforest Capital first reported a position in SpringWorks Therapeutics in Q4 2024 and held it in 2 quarters.
Bayforest Capital's SpringWorks Therapeutics position peaked at $11.4K in Q4 2024.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on Bayforest Capital's 13F filing for Q3 2025, filed 24 Oct 2025.